580 related articles for article (PubMed ID: 16476485)
1. From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions.
Feige JN; Gelman L; Michalik L; Desvergne B; Wahli W
Prog Lipid Res; 2006 Mar; 45(2):120-59. PubMed ID: 16476485
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
3. Nuclear receptors in macrophage biology: at the crossroads of lipid metabolism and inflammation.
Castrillo A; Tontonoz P
Annu Rev Cell Dev Biol; 2004; 20():455-80. PubMed ID: 15473848
[TBL] [Abstract][Full Text] [Related]
4. [Nuclear Receptor PPARs and magnesium].
Fujii H
Clin Calcium; 2005 Nov; 15(11):52-64. PubMed ID: 16272614
[TBL] [Abstract][Full Text] [Related]
5. [PPARs-mediated intracellular signal transduction].
Fujii H
Nihon Rinsho; 2005 Apr; 63(4):565-71. PubMed ID: 15828221
[TBL] [Abstract][Full Text] [Related]
6. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors.
Gelman L; Michalik L; Desvergne B; Wahli W
Curr Opin Cell Biol; 2005 Apr; 17(2):216-22. PubMed ID: 15780600
[TBL] [Abstract][Full Text] [Related]
7. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.
Chinetti-Gbaguidi G; Fruchart JC; Staels B
Curr Opin Pharmacol; 2005 Apr; 5(2):177-83. PubMed ID: 15780828
[TBL] [Abstract][Full Text] [Related]
8. [Anti-inflammatory action of PPARs].
Fujii H
Nihon Rinsho; 2005 Apr; 63(4):609-15. PubMed ID: 15828228
[TBL] [Abstract][Full Text] [Related]
9. Peroxisome proliferator-activated receptors: bridging metabolic syndrome with molecular nutrition.
Guri AJ; Hontecillas R; Bassaganya-Riera J
Clin Nutr; 2006 Dec; 25(6):871-85. PubMed ID: 17052808
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors and atherosclerosis.
Soskić SS; Dobutović BD; Sudar EM; Obradović MM; Nikolić DM; Zarić BL; Stojanović SD; Stokić EJ; Mikhailidis DP; Isenović ER
Angiology; 2011 Oct; 62(7):523-34. PubMed ID: 21467121
[TBL] [Abstract][Full Text] [Related]
11. Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma.
Varga T; Nagy L
Eur J Clin Invest; 2008 Oct; 38(10):695-707. PubMed ID: 18837794
[TBL] [Abstract][Full Text] [Related]
12. PPARs and the placenta.
Fournier T; Tsatsaris V; Handschuh K; Evain-Brion D
Placenta; 2007; 28(2-3):65-76. PubMed ID: 16834993
[TBL] [Abstract][Full Text] [Related]
13. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
Michalik L; Auwerx J; Berger JP; Chatterjee VK; Glass CK; Gonzalez FJ; Grimaldi PA; Kadowaki T; Lazar MA; O'Rahilly S; Palmer CN; Plutzky J; Reddy JK; Spiegelman BM; Staels B; Wahli W
Pharmacol Rev; 2006 Dec; 58(4):726-41. PubMed ID: 17132851
[TBL] [Abstract][Full Text] [Related]
14. PPARs at the crossroads of lipid signaling and inflammation.
Wahli W; Michalik L
Trends Endocrinol Metab; 2012 Jul; 23(7):351-63. PubMed ID: 22704720
[TBL] [Abstract][Full Text] [Related]
15. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
Gervois P; Fruchart JC; Staels B
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):145-56. PubMed ID: 17237841
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
[TBL] [Abstract][Full Text] [Related]
17. PPAR modulation of kinase-linked receptor signaling in physiology and disease.
Rotman N; Wahli W
Physiology (Bethesda); 2010 Jun; 25(3):176-85. PubMed ID: 20551231
[TBL] [Abstract][Full Text] [Related]
18. The selected pathophysiological aspects of PPARs activation.
Kieć-Wilk B; Dembińska-Kieć A; Olszanecka A; Bodzioch M; Kawecka-Jaszcz K
J Physiol Pharmacol; 2005 Jun; 56(2):149-62. PubMed ID: 15985699
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptors: potential therapeutic targets in lung disease?
Denning GM; Stoll LL
Pediatr Pulmonol; 2006 Jan; 41(1):23-34. PubMed ID: 16267824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
